Neuralink, Elon Musk's brain implant startup, set to begin human trials<br />Neuralink, Elon Musk's biotechnology startup, is about to embark on its first human clinical trial.<br />The trial, called the PRIME Study, aims to evaluate the safety and functionality of brain implants for paralysis patients.<br />The implants will be placed in the part of the brain that controls movement intention.<br />A chip, installed by a robot, will record and send brain signals to an app.<br />The initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.<br />Individuals with quadriplegia due to spinal cord injury or ALS may qualify for the six-year-long study.<br />Interested individuals can sign up on Neuralink's website.<br />Elon Musk has been working on Neuralink's goal of connecting the human brain to a computer for five years.<br />Inspired by science fiction authors, Musk envisions a "neural lace" technology that can connect all of a person's thoughts to a computer.<br />While Neuralink has previously tested on animals, the company is now ready to move forward with human trials.<br />Neuralink faced scrutiny after a monkey died during testing, but the company has addressed safety concerns and obtained FDA clearance for human trials.<br />The startup also recently raised $280 million in a fundraising round.<br />With regulatory approval still needed before the implants hit the market, Neuralink is making significant progress in its mission to revolutionize brain-computer interfaces.<br />Neuralink's upcoming human trials mark a major milestone in the field of brain implants.<br />With the potential to restore movement and independence for paralysis patients, this groundbreaking technology could change lives.<br />Stay tuned for updates on Neuralink's progress as they continue to push the boundaries of innovation.<br />#latestnews #news #cnn
